More than 3800 candidemias are diagnosed annually in our country that require at least 15 days of treatment and the immediate removal of the catheters, which must be replaced. However, the catheter is only responsible in half of the cases, and could have not be removed, avoiding unnecessary morbidity and cost. The methods we use for bacteria, fail to identify the catheters involved in the candidemias before their removal (tip sent to the laboratory). Objective: To determine if the use of new diagnostic methods, not based on culture, allows the accurate identification of patients in whom the catheter is the origin of the candidemia (CRC) before catheter removal. Scope: Three Spanish REIPI, CIBERESP and CIBERES centres and an Italian hospital. Study subjects: adults with candidemia and a catheter not yet removed. Methodology: Epidemiological cohort study, prospective, multicenter. Levels of 1-3 BDG, CAGTA, presepsin and Candida PCR in catheter-drawn and peripheral vein blood will be compared. Before removing the catheter, skin and hubs cultures and differential blood cultures will be performed and when removing the catheter, following current guidelines, we will perform tip culture (Maki and sonication), quantitative panfungal PCR and sequencing of the blood and catheter strains (gold standard), as well as biofilm and biomass production of all strains. A PET-CT will be done to identify previously undetected distant metastases. Analysis of the results: The accuracy of the new biomarkers, PCR and PET-CT in CRC diagnosis will be studied evaluating the possibility of confirming it with certainty without the need to remove catheters unnecessarily. This large case series of CRC and CN-RC will lay the foundation for a future clinical trial of personalized treatment of candidemia using the new diagnostic strategies evaluated.
Candidemia Candidemia relacionada con el Catéter 3
Non culture-based diagnosis Genotipado Candida Biofilm y biomasa Antifúngicos Beta De Glucado PET –CT GAGTA Hemocultivosltures
Acción Estratégica en Salud (AES)
01/01/2021 - 31/12/2023
PATRICIA CARMEN MUÑOZ GARCIA
FUNDACION INVESTIGACION BIOMEDICA HOSPITAL GREGORIO MARAÑON
INSTITUTO DE INVESTIGACION SANITARIA GREGORIO MARAÑON (IiSGM)
MADRID
MADRID
196,020 €